Effect of pemvidutide, a GLP-1/glucagon dual receptor agonist, on MASLD: A randomized, double-blind, placebo-controlled study. Harrison SA, Browne SK, Suschak JJ, Tomah S, et al. J Hepatol 2025;82:7-17.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Harrison SA, Browne SK, Suschak JJ, Tomah S, et al. Effect of pemvidutide, a GLP-1/glucagon dual receptor agonist, on MASLD: A randomized, double-blind, placebo-controlled study. J Hepatol 2025;82:7-17.
PMID: 39002641